Liquidia (LQDA) Receivables (2021 - 2026)
Liquidia (LQDA) posted quarterly Receivables of $74.2 million for Q1 2026, up 5846.83% year-over-year from $1.2 million in Q1 2025, and up 37.09% quarter-over-quarter from $54.1 million in Q4 2025.
Liquidia (LQDA) Receivables (2021 - 2026) Analysis & Trends
Liquidia's Receivables history runs 6 years deep, the most recent figure standing at $74.2 million for Q1 2026.
- In Q1 2026, Receivables rose 5846.83% year-over-year to $74.2 million; the TTM figure through Mar 2026 stood at $74.2 million (up 5846.83% YoY), while the FY2025 annual figure was $54.1 million, up 1889.44% from the prior year.
- Receivables for Q1 2026 stood at $74.2 million, up from $54.1 million in the prior quarter.
- The five-year high for Receivables was $74.2 million in Q1 2026, with the low at $1.2 million in Q1 2025.
- The 5-year median for Receivables is $4.1 million (2023), against an average of $12.9 million.
- The sharpest annual moves came in 2025 and 2026: Receivables slumped 51.48% in 2025, then jumped 5846.83% in 2026.
- Liquidia's Receivables stood at $5.0 million in 2022, then slipped by 19.06% to $4.1 million in 2023, then tumbled by 33.05% to $2.7 million in 2024, then surged by 1889.44% to $54.1 million in 2025, then surged by 37.09% to $74.2 million in 2026.
- Business Quant data shows LQDA's Receivables at $74.2 million in Q1 2026, $54.1 million in Q4 2025, and $36.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Liquidia | 6.37 Bn | 6.09 Bn | 160.92 Mn | 108.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.58 Mn |
| Mar 31, 2026 | 74.16 Mn |
| Dec 31, 2025 | 54.09 Mn |
| Sep 30, 2025 | 35.96 Mn |
| Jun 30, 2025 | 9.97 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 3.34 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 5.02 Mn |
| Sep 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 3.75 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 3.05 Mn |